Opthea Ltd (OPT)
3.39
-0.35
(-9.36%)
USD |
NASDAQ |
Nov 14, 16:00
3.39
0.00 (0.00%)
After-Hours: 20:00
Opthea Enterprise Value: 544.62M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 544.62M |
| November 12, 2024 | 604.02M |
| November 11, 2024 | 616.18M |
| November 08, 2024 | 601.56M |
| November 07, 2024 | 590.79M |
| November 06, 2024 | 611.71M |
| November 05, 2024 | 613.87M |
| November 04, 2024 | 616.95M |
| November 01, 2024 | 636.95M |
| October 31, 2024 | 640.03M |
| October 30, 2024 | 639.57M |
| October 29, 2024 | 673.88M |
| October 28, 2024 | 658.50M |
| October 25, 2024 | 610.79M |
| October 24, 2024 | 615.61M |
| October 23, 2024 | 667.71M |
| October 22, 2024 | 655.42M |
| October 21, 2024 | 735.44M |
| October 18, 2024 | 736.98M |
| October 17, 2024 | 742.98M |
| October 16, 2024 | 750.83M |
| October 15, 2024 | 724.67M |
| October 14, 2024 | 723.13M |
| October 11, 2024 | 758.52M |
| October 10, 2024 | 692.35M |
| Date | Value |
|---|---|
| October 09, 2024 | 693.71M |
| October 08, 2024 | 680.63M |
| October 07, 2024 | 693.89M |
| October 04, 2024 | 658.50M |
| October 03, 2024 | 655.37M |
| October 02, 2024 | 676.96M |
| October 01, 2024 | 680.81M |
| September 30, 2024 | 595.40M |
| September 27, 2024 | 580.01M |
| September 26, 2024 | 584.63M |
| September 25, 2024 | 602.85M |
| September 24, 2024 | 567.70M |
| September 23, 2024 | 569.24M |
| September 20, 2024 | 579.81M |
| September 19, 2024 | 563.09M |
| September 18, 2024 | 507.92M |
| September 17, 2024 | 494.38M |
| September 16, 2024 | 480.76M |
| September 13, 2024 | 453.87M |
| September 12, 2024 | 453.83M |
| September 11, 2024 | 446.13M |
| September 10, 2024 | 439.98M |
| September 09, 2024 | 452.29M |
| September 06, 2024 | 413.82M |
| September 05, 2024 | 427.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.24M
Minimum
Jun 27 2024
758.52M
Maximum
Oct 11 2024
288.56M
Average
253.48M
Median
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Mesoblast Ltd | -- |
| Immuron Ltd | 3.484M |
Enterprise Value Related Metrics
| Earnings Yield | -81.44% |
| Normalized Earnings Yield | -77.35 |